New generation antipsychotic drugs and compliance behaviour

Current Opinion in Psychiatry - Tập 21 Số 2 - Trang 133-139 - 2008
Lakshmi P. Voruganti1, Laura K Baker1, A. George Awad2
1McMaster University, Hamilton, Ontario, Canada
2University of Toronto, Toronto, Ontario, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

DiMatteo, 2002, Med Care, 40, 794, 10.1097/00005650-200209000-00009

Osterberg, 2005, N Engl J Med, 353, 487, 10.1056/NEJMra050100

McEvoy, 1984, J Nerv Ment Dis, 172, 412, 10.1097/00005053-198407000-00007

Velligan, 2006, Schizophr Bull, 32, 724, 10.1093/schbul/sbj075

Sackett, 1976

Steiner, 1988, Med Care, 26, 814, 10.1097/00005650-198808000-00007

Valenstein, 2002, Med Care, 40, 630, 10.1097/00005650-200208000-00002

Hamilton, 1992, Am J Hosp Pharm, 49, 1691

Steiner, 1997, J Clin Epidemiol, 50, 105, 10.1016/S0895-4356(96)00268-5

Thompson, 2000, Schizophr Res, 42, 241, 10.1016/S0920-9964(99)00130-9

Kemp, 1996, Br J Psychiatry, 169, 444, 10.1192/bjp.169.4.444

Weiden, 1994, Schizophr Bull, 20, 297, 10.1093/schbul/20.2.297

Awad, 1993, Schizophr Bull, 19, 609, 10.1093/schbul/19.3.609

Naber, 1995, Int Clin Psychopharmacol, 10, 133

Voruganti, 2002, Schizophr Res, 56, 37, 10.1016/S0920-9964(01)00161-X

Wyatt, 1991, Schizophr Bull, 17, 325, 10.1093/schbul/17.2.325

Nose, 2003, Psychol Med, 33, 1149, 10.1017/S0033291703008328

Hogarty, 2004, Am J Psychiatry, 161, 581, 10.1176/appi.ajp.161.3.581-a

Coldham, 2002, Acta Psychiatr Scand, 106, 286, 10.1034/j.1600-0447.2002.02437.x

Hawton, 2005, Br J Psychiatry, 187, 9, 10.1192/bjp.187.1.9

Lacro, 2002, J Clin Psychiatry, 63, 892, 10.4088/JCP.v63n1007

Lieberman, 1996, J Clin Psychiatry, 57, 68

Voruganti, 2004, Psychopharmacology (Berl), 171, 121, 10.1007/s00213-003-1648-y

Simpson, 2005, Am J Manag Care, 11, S235

Awad, 2004, CNS Drugs, 18, 877, 10.2165/00023210-200418130-00004

Mortimer, 2007, Int J Soc Psychiatry, 53, 99, 10.1177/0020764006075000

Perkins, 2006, Schizophr Res, 83, 53, 10.1016/j.schres.2005.10.016

Nakonezny, 2006, Schizophr Res, 82, 107, 10.1016/j.schres.2005.10.015

Lieberman, 2005, N Engl J Med, 353, 1209, 10.1056/NEJMoa051688

Stroup, 2003, Schizophr Bull, 29, 15, 10.1093/oxfordjournals.schbul.a006986

Silva de Lima, 2005, J Clin Psychiatry, 66, 831, 10.4088/JCP.v66n0704

Haro, 2005, Acta Psychiatr Scand, 111, 220, 10.1111/j.1600-0447.2004.00450.x

Diaz, 2004, J Clin Psychiatry, 65, 354, 10.4088/JCP.v65n0311

Csernansky, 2002, N Engl J Med, 346, 16, 10.1056/NEJMoa002028

Dolder, 2002, Am J Psychiatry, 159, 103, 10.1176/appi.ajp.159.1.103

Al-Zakwani, 2003, Curr Med Res Opin, 19, 619, 10.1185/030079903125002270

Gibson, 2004, Value Health, 7, 22, 10.1111/j.1524-4733.2004.71272.x

Eaddy, 2005, Clin Ther, 27, 263, 10.1016/j.clinthera.2005.02.003

Ren, 2006, J Clin Pharm Ther, 31, 57, 10.1111/j.1365-2710.2006.00711.x

Gianfrancesco, 2006, Psychiatry Res, 144, 177, 10.1016/j.psychres.2006.02.006

Cooper, 2007, J Clin Psychiatry, 68, 818, 10.4088/JCP.v68n0601

Vanelli, 2001, Psychiatr Serv, 52, 1248, 10.1176/appi.ps.52.9.1248

Menzin, 2003, Psychiatr Serv, 54, 719, 10.1176/appi.ps.54.5.719

Rijcken, 2004, Pharmacoepidemiol Drug Saf, 13, 365, 10.1002/pds.951

Valenstein, 2004, Schizophr Bull, 30, 255, 10.1093/oxfordjournals.schbul.a007076

Gilmer, 2004, Am J Psychiatry, 161, 692, 10.1176/appi.ajp.161.4.692

Van Putten, 1987, J Clin Psychiatry, 48, 13

Hogan, 1983, Psychol Med, 13, 177, 10.1017/S0033291700050182

Löffler, 2003, Pharmacopsychiatry, 36, 105, 10.1055/s-2003-39985

Naber, 2005, Acta Psychiatr Scand Suppl, 427, 29, 10.1111/j.1600-0447.2005.00542.x

Voruganti, 2002, Schizophr Res, 57, 201, 10.1016/S0920-9964(01)00309-7

Cabeza, 2000, Schizophr Res, 41, 349, 10.1016/S0920-9964(99)00079-1

Swanson, 2004, Schizophr Bull, 30, 3, 10.1093/oxfordjournals.schbul.a007065

Velligan, 2003, Psychiatr Serv, 54, 665, 10.1176/appi.ps.54.5.665

Wahlbeck, 2001, Psychopharmacology, 155, 230, 10.1007/s002130100711

Nasrallah, 2007, Acta Psychiatr Scand, 115, 260, 10.1111/j.1600-0447.2006.00982.x